Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
11/2000
11/02/2000EP1047665A1 Matrix metalloprotease inhibitors
11/02/2000CA2371308A1 Tri-aryl acid derivatives as ppar receptor ligands
11/02/2000CA2371224A1 Polyaldimines of oligomeric aminobenzoic acid derivatives, and their use for preparation of moisture-curable, storage-stable, one-part polyureas
11/02/2000CA2369552A1 Agent for prophylaxis and treatment of angiostenosis
11/02/2000CA2369092A1 Heterosubstituted pyridine derivatives as pde 4 inhibitors
11/02/2000CA2367695A1 Heteroaryl diazacycloalkanes, their preparation and use
11/01/2000CN1272107A Benzamidine derivatives as factor Xa inhibitors
11/01/2000CN1272106A Acylsulfamoyl benzoic acid amides, plant protection agents containing same, and method for producing same
11/01/2000CN1271723A Preparation of tirt nitrile substituted aromatic compound
11/01/2000CN1058004C Heterocyclo-benzoylguanidin
11/01/2000CN1058001C 4-Mercaptobenzoylguanidine derivatives
11/01/2000CN1057999C 4-Aminobenzoylguanidine derivatives
10/2000
10/31/2000US6141137 Electrochromic media for producing a preselected color
10/31/2000US6140504 Substituted intermediate compounds for the preparation of n-[(aminoiminomethyl or aminomethyl)phenyl]propyl amides
10/31/2000US6140368 Viricidal properties against retroviruses; inhibitors of hiv reverse transcriptase and/or hiv integrase; aids therapy; nontoxic; also topical treatment of retroviral diseases, e.g. herpes simplex.
10/31/2000US6140362 Method for inhibiting the growth of mammalian cells
10/31/2000US6140361 For inhibiting binding of human immunodeficiency virus rev protein to rev responsive elements (rre)
10/31/2000US6140356 Opthalmic pharmaceutical compositions comprising a nitrone compound and methods for treating ocular inflammation using such compositions
10/31/2000US6140354 N-substituted aminotetralins as ligands for the neuropeptide Y Y5 receptor useful in the treatment of obesity and other disorders
10/31/2000US6140353 Used as medicaments for the treatment and/or prevention of thromboses, apoplexy, cardiac infarction, inflammation and arteriosclerosis or as antitumor agents
10/31/2000US6139769 Bleaching-active metal complexes
10/31/2000US6139603 Process for recovering oxygen
10/26/2000WO2000063218A1 Ruthenium dimeric complexes suitable as antimetastatic and antineoplastic agents
10/26/2000WO2000063178A1 Dibenzoazulene derivatives for treating thrombosis, osteoporosis, arteriosclerosis
10/26/2000WO2000063177A1 Method of producing chloropyridine sulfonic acid chlorides
10/26/2000WO2000063176A2 Disubstituted pyridines and pyrimidines as herbicides and fungicides
10/26/2000WO2000063175A2 Novel process
10/26/2000WO2000063174A1 Novel process
10/26/2000WO2000063166A1 Carbamic acid derivatives and their use as metabotropic glutamate receptor ligands
10/26/2000WO2000063165A1 Mmp inhibitor
10/26/2000WO2000063153A1 New compounds, their preparation and use
10/26/2000WO2000063140A1 Template directed solid-state organic synthesis
10/26/2000WO2000062778A1 Cyclic protein tyrosine kinase inhibitors
10/26/2000WO2000062767A2 Pharmaceutical compositions containing pyridine or pyrimidine derivates for inhibition of cytokine production and secretion
10/26/2000CA2370146A1 Ruthenium dimeric complexes suitable as antimetastatic and antineoplastic agents
10/26/2000CA2367359A1 Dibenzoazulene derivatives for the treatment of thrombosis, osteoporosis, arteriosclerosis
10/26/2000CA2367356A1 New compounds, their preparation and use
10/25/2000EP1046635A1 Process for preparing an aromatic compound substituted by a tertiary nitrile
10/25/2000EP1046627A2 Enantiopure reagents and process for the separation of enantiomers
10/25/2000EP1046393A1 Composition containing at least one bicyclic aromatic compound and at least one 2-alkyl-1-alkanol or an ester, and its use
10/25/2000EP1045836A1 Pyridones as src family sh2 domain inhibitors
10/25/2000EP0979208A4 Composition and method for reducing copper oxide to metallic copper
10/25/2000EP0912517B1 Method of preparing phosphodiesterase iv inhibitors
10/25/2000CN1271354A Compounds possessing neuronal activity
10/25/2000CN1271348A Method for producing (hetero) aromatic hydroxylamines
10/25/2000CN1271346A Method for producing substituted 2-nitroguanidine derivative
10/25/2000CN1271345A Method for producing substituted 2-nitroguanideine derivatives
10/25/2000CN1271344A Supernucleophilic 4-substituted-pyridine catalysts, and processes ofr preparing same
10/25/2000CN1270959A 4-phenyl pyridine derivatives
10/24/2000US6137002 Glycoprotein IIb/IIIa antagonists
10/24/2000US6136982 Reacting ethylcyanoacetate with acetone; treating product with n,n-dimethylformamide dimethyl acetal; reactionwith hydrogen chloride in ethanol to cyclize; hydrolysis; reaction with thionyl chloride then anhydrous ammonia; hoffmann reaction
10/24/2000US6136837 α-substituted benzyl heterocyclic derivatives, intermediates for producing the same and agrochemical composition containing the same as active ingredient
10/24/2000US6136754 Intermediates for pyridyl-thiazoles and their use to protect plants against infections by micro-organisms
10/24/2000US6136335 Phenethyl-5-bromopyridylthiourea (PBT) and dihydroalkoxybenzyloxopyrimidine (DABO) derivatives exhibiting spermicidal activity
10/21/2000CA2305944A1 Process for separating enantiomers and enantiopur reagent
10/19/2000WO2000061590A1 Process for preparing amine platinum complexes
10/19/2000WO2000061561A1 Cyanoguanidine compounds
10/19/2000WO2000061560A1 Novel compounds
10/19/2000WO2000061559A1 N-substituted cyanoguanidine compounds
10/19/2000WO2000061556A1 Nitrogen-containing heterocyclic compounds and benamide compounds and drugs containing the same
10/19/2000WO2000061134A1 Antimicrobial agents
10/19/2000DE19931873A1 Katalysatorsystem zur Olefinpolymerisation A catalyst system for olefin polymerization
10/19/2000DE19917160A1 New disubstituted pyridine or pyrimidine derivatives, useful as total or selective herbicides or as microbicides, especially fungicides, for plant protection
10/19/2000DE19916837A1 New di- or tetrahydro-benzoazulene derivatives, are integrin inhibitors useful e.g. for treating thrombosis, coronary heart disease, arteriosclerosis, tumors, osteoporosis or rheumatoid arthritis
10/19/2000CA2369103A1 Nitrogen-containing heterocyclic compounds and benamide compounds and drugs containing the same
10/19/2000CA2305942A1 Composition containing at least one aromatic bicyclic compound and at least one 2-alkyl alcan-1-ol or an ester, and its uses
10/18/2000EP1044992A1 Catalytic system for the polymerisation of olefin
10/18/2000EP1044967A2 2-Pyridinylguanidine urokinase inhibitors
10/18/2000EP1044188A1 Acylated 4-aminopyridine derivatives as pesticides and fungicides
10/18/2000EP1044187A1 N-benzyl-3-indenylacetamides derivatives for treating neoplasia
10/18/2000EP1043999A1 Novel substituted pyridine compounds useful as modulators of acetylcholine receptors
10/18/2000CN1270581A 2,6-dichloro-4-pyridinemethanol derivatives and agricultural chemicals
10/18/2000CN1270168A Magnolol series of compounds, synthesizing process thereof, and medicinal composition using same as active component
10/18/2000CN1057522C Naphthalene derivs. as prostaglandin I2 agonists
10/17/2000US6133450 Process for recovery of pyridine-2,3-dicarboxylic acid
10/17/2000US6133449 Processes and intermediates for the preparation of piperazine derivatives
10/17/2000US6133448 Aromatic compound is added to a solution of dinitrogen pentaoxide in an organic solvent and the provided reaction mixture is thereafter added into water comprising a nucleophile
10/17/2000US6133447 Reacting 3-hydroxypyridine with sodium hypochlorite in an aqueous medium
10/17/2000US6133442 For the treatment of disorders which are associated with endothelin activities, especially circulatory disorders such as hypertension, ischaemia, vasospasms and angina pectoris
10/17/2000US6133432 Processes for preparing pesticidal intermediates
10/17/2000US6133297 4-((substituted)amino(substituted)alkylcarbonylamino (subtituted)alkylamino)pyridine compounds of given formula; administering to treat thrombosis
10/17/2000US6133296 Substituted pyridyl keto enols
10/17/2000US6133284 Excellent bactericidal properties and oral absorption; infections from gramnegative and -positive bacteria; intestinal absorption, metabolic stability; side effect reduction; nonphototoxicity and noncytotoxicity
10/17/2000US6133283 Mono- or polyenic carboxylic acid derivatives
10/17/2000US6133272 Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses
10/17/2000US6133268 1,4-disubstituted piperazines
10/17/2000US6133265 Treating physiological disorders associated with an excess of neuropeptide y, such as eating disorders, e.g., obesity, bulimia, and certain cardiovascular diseases, e.g., hypertension
10/14/2000CA2305119A1 A catalyst system for olefin polymerization
10/13/2000CA2305047A1 2-pyridinylguanidine urokinase inhibitors
10/12/2000WO2000060044A1 Composition and method for bleaching a substrate
10/12/2000WO2000060043A1 Composition and method for bleaching a substrate
10/12/2000WO2000059880A1 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
10/12/2000WO2000059878A2 INHIBITORS OF LFA-1 BINDING TO ICAMs AND USES THEREOF
10/12/2000WO2000059875A2 Novel inhibitors of formation of advanced glycation endproducts (age's)
10/12/2000WO2000059874A1 NOVEL AMIDE DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEINASES, TNF-α, AND AGGRECANASE
10/12/2000WO2000059868A1 Substituted aniline compounds
10/12/2000WO2000059862A2 Processes for preparing pesticidal intermediates
10/12/2000WO2000059487A2 Flupirtine in the treatment of fibromyalgia and related conditions
10/12/2000WO1998025597A3 Method for treating and preventing heart failure and ventricular dilatation
10/12/2000CA2369238A1 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
1 ... 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 ... 633